Department for International Trade

Leading the UK delegation

  • UK team
  • US team
  • North America Lead – John Hoggard 
  • Mexico – Pablo Velasco
  • Brazil and Latin America and the Caribbean – Juliana Caires and Laura Moreira
  • Company type
    Hannah Williams
    Biopharma Lead 

    Department for International Trade - Midlands region

    Leading the Midlands delegation
    The Department for International Trade (DIT) helps businesses export, drives inward and outward investment, negotiates market access and trade deals, and champions free trade.

    Company type
    Louise Stock
    Healthcare & Life Science Sector Specialist 

    Invest Northern Ireland

    Leading the Northern Ireland delegation

    Company type
    Philip McCann
    Michael Conlon
    Brendan Mcguigan

    Scottish Development International

    Leading the Scotland delegation 
    Carcinotech, Causeway Therapeutics, DeepMatter, Elasmogen, Ingenza, Symbiosis, Pneumagen, TC Biopharm.

    Company type
    Jan Malek
    Melina Hernandez
    David Yeary



    Company type

    Almac Discovery

    Almac Discovery is a research driven drug discovery company dedicated to the development of novel and innovative approaches to the treatment of diseases of unmet need (including oncology and CNS), by applying a target class approach. The Almac Discovery business model is to develop preclinical stage assets which are then licenced to pharmaceutical or biotech partners for further development. We also look to collaborate with partners to apply our medicinal chemistry and translational biology expertise to targets of mutual interest. Key research themes include deubiquitinase enzymes and protein drug conjugates.

    Company type
    Alan Lamont
    LinkedIn logo VP Business Development and licensing 


    Arctoris is a tech-enabled drug discovery company headquartered in Oxford and Boston. Arctoris combines its unique automation platform, Ulysses, with advanced computational approaches and a world-class team of seasoned drug hunters to guide and rapidly progress its wholly owned and partnered drug discovery programs in oncology and neurology.

    Company type
    Martin-Immanuel Bittner
    LinkedIn logo Co-Founder and CEO 

    BiologIC Technologies

    Company type
    Richard Vellacott

    Birmingham University

    Company type